MAXIMUS (MMS) Tops Q2 EPS by 26c; beats on guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MMS Hot Sheet
Price: $68.51 +4.66%
EPS Growth %: +42.6%
Financial Fact:
Operating income from continuing operations: 81.31M
Today's EPS Names:
CIX, ARIS, COHR, More
EPS Growth %: +42.6%
Financial Fact:
Operating income from continuing operations: 81.31M
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
MAXIMUS (NYSE: MMS) reported Q2 EPS of $0.80, $0.26 better than the analyst estimate of $0.54. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.2 billion.
GUIDANCE:
MAXIMUS sees FY2023 EPS of $4.00-$4.30, versus the consensus of $3.61. MAXIMUS sees FY2023 revenue of $4.85-5 billion, versus the consensus of $4.94 billion.
For earnings history and earnings-related data on MAXIMUS (MMS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- 8x8, Inc. (EGHT) Reports In-Line Q2 EPS
- Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
